Claret Capital Partners exceeds target with €575M growth debt fund for European innovators

Claret Capital Partners has closed its fourth European Growth Capital Fund at €575 million, exceeding its €500 million target. Including affiliated discretionary mandates, the fund will make growth debt investments in technology, life sciences and impact-focused companies across Europe. The fund has already deployed 32 per cent of its capital, backing more than 27 companies including B2B buy-now-pay-later platform Billie, clinical-stage pharmaceutical company Cinclus Pharma, commercial real esta